Status:
COMPLETED
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
Lead Sponsor:
Sykehuset Innlandet HF
Collaborating Sponsors:
Demensforbundet, Norway
Conditions:
Dementia
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).
Detailed Description
Patients with dementia have cognitive deficits, but also hallucinations, delusions, agitation, aggression and apathy. These symptoms are called Behavioural- and Psychological Symptoms in Dementia (BPS...
Eligibility Criteria
Inclusion
- Vascular- or Alzheimer Dementia
- Nursing Homes resident for 3 months or more
- Given antipsychotics or antidepressants for 3 months or more
- Clinical Dementia rating 1, 2 or 3
Exclusion
- Dementia of other origin
- Psychiatric disease
- Life expectancy less than 3 months
- Acute infection last 10 days
- Unstable Diabetes Mellitus
- Terminal disease
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00433121
Start Date
September 1 2006
End Date
August 1 2007
Last Update
August 24 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sykehuset Innlandet HF - Sanderud
Ottestad, Oppland, Norway, 2312